[1] ChobanianAV,BakrisGL,BlackHR,CushmanWC,GreenLA,IzzoJL, 2003.Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure,Hypertension 42 1206 -52
[2] IqbalR,AhmadZ,MalikF,MahmoodS,ShahzadiN,MehwishS, 2012.A statistical analysis of hypertension as cardiovascular risk factor,Middle East J Sci Res 12 19 -22
[3] CossioY,AlexanderS, 2007.Human physiology: From cells to systems, 382 -
[4] MalpasSC, 2010.Sympathetic nervous system overactivity and its role in the development of cardiovascular disease,Physiol Rev 90 513 -57
[5] D'Agostino,RB , Vasan,RS , Pencina,MJ , Wolf,PA , Cobain,M , Massaro,JM, 2008.General cardiovascular risk profile for use in primary care the Framingham Heart Study,Circulation 117 743 -53
[6] World Health Organization (WHO). Global database on
body mass index. BMI classification. 2013, (Cited date: 29
July 2017) Website: [ http://apps.who.int/bmi/ ]. -
[7] RomeroR,BonetJ,De La SierraA,AguileraMT, 2007.Undiagnosed obesity in hypertension: clinical and therapeutic implications,Blood Pressure 16 347 -53
[8] HallJE,KuoJJ,da SilvaAA,de PaulaRB,LiuJ,TallamL, 2003.Obesity-associated hypertension and kidney disease,Curr Opin Nephrol Hypertens 12 195 -200
[9] KumanyikaSK,ObarzanekE,StettlerN,BellR,FieldAE,FortmannSP, 2008.Population-based prevention of obesity,Circulation 118 428 -64
[10] ShaheenA,NazliR,FatimaS,AliR,KhanI,KhattakS. Adipokine, 2016.Serum visfatin level in pregnancy induced hypertension and uncomplicated pregnancy,Pak J Med Sci 32 1419 -24
[11] SonoliSS,ShivprasadS,PrasadCV,PatilAB,DesaiPB,SomannavarMS, 2011.Visfatin - a review,Eur Rev Med Pharmacol Sci 15 9 -14
[12] TaskesenD,KirelB,UsT., 2012.Serum visfatin levels, adiposity and glucose metabolism in obese adolescents,J Clin Res Pediatr Endocrinol 4 76 -81
[13] GuzikTJ,MangalatD,Korbut R. Adipocytokines, 2006.- novel link between inflammation and vascular function?,J Physiol Pharmacol 57 505 -28
[14] RotkegelS,ChudekJ,Spiechowicz-ZatonU,FicekR,AdamczakM, 2013.Wiecek A. The Effect of Sodium Restricted Diet on Plasma Visfatin Levels in Hypertensive Patients with Visceral Obesity, 37 124 -31
[15] MuJ,FengB,YeZ,YuanF,ZengW,LuoZ, 2011.Visfatin is related to lipid dysregulation, endothelial dysfunction and atherosclerosis in patients with chronic kidney disease,J Nephrol 24 177 -84
[16] TaddeiS,VirdisA,GhiadoniL,SudanoI,SalvettiA, 2001.Endothelial dysfunction in hypertension,J Cardiovasc Pharmacol 38 11 -14
[17] RezkMY, 2014.Visfatin and cardiovascular protection,Journal of Drug Delivery and Therapeutics 4 154 -66
[18] LimSY,DavidsonSM,ParamanathanAJ,SmithCC,YellonDM,Hausenloy DJ, 2008.The novel adipocytokine visfatin exerts direct cardioprotective effects,J Cell Mol Me 12 1395 -1403
[19] 2017.Waist circumference and waist-hip ratio: Report of a WHO expert consultation,[Retrieved on 29 July 8 -
[20] GunesF,AkbalE,CakirE,AkyurekO,AltunbasM,OzbekM., 2011.Visfatin may be a novel marker for identifying stages of essential hypertension in advanced age patients,Intern Med 51 553 -57
[21] OzalE,SahinI,BolatI,PusurogluH,AvciII,AkgulO, 2017.Visfatin levels are increased in patients with resistant hypertension and are correlated with left ventricular hypertrophy,Blood Pressure Monitoring 22 137 -42
[22] DogruT,SonmezA,TasciI,YilmazMI,ErdemG,ErturkH, 2007.Plasma visfatin levels in young male patients with uncomplicated and newly diagnosed hypertension,J Hum Hypertens 21 173 -75
[23] BalistreriCR,CarusoC,CandoreG., 2010.The role of adipose tissue and adipokines in obesity-related inflammatory diseases,Mediat Inflamm 1 -9
[24] Rui-zhenLI,Xin-yuMA,Hui-lingLU,HuiYAO,Shou-kangCHEN,Si-xiuKANG, 2013.Study of visfatin, ASP level in obese children and their clinical significance,Int J Pediatr Oncol 40 -
[25] GoktasZ,WangS, 2012.Visfatin and RBP4 gene expression levels in different adipose tissues and insulin resistance,In: BMC Proceedings 6 1 -17
[26] HaiderDG,SchallerG,KapiotisS,MaierC,LugerA,WolztM., 2006.The release of the adipocytokine visfatin is regulated by glucose and insulin,Diabetologia 49 1909 -14
[27] WangP,DuH,ZhangRY,GuanYF,XuTY,XuQY, 2010.Circulating and local visfatin/Nampt/PBEF levels in spontaneously hypertensive rats, stroke-prone spontaneously hypertensive rats and Wistar-Kyoto rats,J Physiol Sci 60 317 -24
[28] BerndtJ,KlötingN,KralischS,KovacsP,FasshauerM,SchönMR, 2005.Plasma visfatin concentrations and fat depot-specific mRNA expression in humans,Diabetes 54 2911 -16